|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12Q 1/6886 | (2018.01) |
| (11) | Number of the document | 3640345 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19210527.8 |
| Date of filing the European patent application | 2016-08-16 | |
| (97) | Date of publication of the European application | 2020-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
| (46) | Date of publication of the claims translation | 2022-01-10 |
| (30) | Number | Date | Country code |
| 201562206194 P | 2015-08-17 | US | |
| 201562218927 P | 2015-09-15 | US | |
| 201562241019 P | 2015-10-13 | US | |
| 201662310582 P | 2016-03-18 | US | |
| 201662372662 P | 2016-08-09 | US |
| (72) |
GUALBERTO, Antonio , US
SCHOLZ, Catherine Rose , US
|
| (73) |
Kura Oncology, Inc. ,
12730 High Bluff Drive, Suite 400, San Diego, CA 92130,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Vėžiu sergančių pacientų gydymo būdai farneziltransferazės inhibitoriais |
| METHODS OF TREATING CANCER PATIENTS WITH FARNESYL TRANSFERASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2023-07-20 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-08-16 |